Core Scientific, Inc.
CORZ
$19.58
-$0.21-1.04%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 67.57% | 126.45% | |||
| Total Other Revenue | -28.47% | -28.60% | |||
| Total Revenue | 42.48% | 44.48% | |||
| Cost of Revenue | 10.59% | 101.19% | |||
| Gross Profit | 132.66% | -19.60% | |||
| SG&A Expenses | 9.32% | 17.70% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 42.85% | -89.37% | |||
| Total Operating Expenses | 11.72% | -3.86% | |||
| Operating Income | 152.18% | 65.45% | |||
| Income Before Tax | -232.79% | -261.77% | |||
| Income Tax Expenses | 217.83% | 531.58% | |||
| Earnings from Continuing Operations | -232.76% | -262.12% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -232.76% | -262.12% | |||
| EBIT | 152.18% | 65.45% | |||
| EBITDA | 637.53% | 89.73% | |||
| EPS Basic | -213.34% | -279.59% | |||
| Normalized Basic EPS | -1,733.18% | -121.27% | |||
| EPS Diluted | -213.34% | -360.76% | |||
| Normalized Diluted EPS | -1,733.18% | -130.92% | |||
| Average Basic Shares Outstanding | 0.75% | 1.04% | |||
| Average Diluted Shares Outstanding | 0.75% | -30.49% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||